ConductScience.org, home

Paper9260591

p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.

Günther T and 4 others. J Cancer Res Clin Oncol, 1997. Cited by 28 papers, by iCite.

Cite this record

ConductScience Library. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors. Papers, record 9260591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9260591

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
PubMed
Journal
J Cancer Res Clin Oncol
PubMed
Year
1997
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
28
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2025-07-19
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Günther TT
2Schneider-Stock RR
3Rys JJ
4Niezabitowski AA
5Roessner AA

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Breast NeoplasmsMajor topic
CarcinomaMajor topic
Genes, p53Major topic
Nuclear ProteinsMajor topic
Proto-Oncogene ProteinsMajor topic
Tumor Suppressor Protein p53Major topic
Adult
Aged
DNA, Neoplasm
Female
Gene Expression Regulation, Neoplastic
Humans
Middle Aged
Mutation
Ploidies
Point Mutation
Polymorphism, Single-Stranded Conformational
Proto-Oncogene Proteins c-mdm2
Receptors, Estrogen

Source PubMed

Download CSV of topics

References40

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18423618Prognostic significance of p53 overexpression in node-negative breast carcinoma: preliminary studies support cautious optimism.J Natl Cancer Inst1993https://conductscience.org/library/papers/8423618PubMed
21464323The transcriptional transactivation function of wild-type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein.EMBO J1992https://conductscience.org/library/papers/1464323PubMed
31505019p53 function and dysfunction.Cell1992https://conductscience.org/library/papers/1505019PubMed
42687159Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction.Genomics1989https://conductscience.org/library/papers/2687159PubMed
51984541NIH consensus conference. Treatment of early-stage breast cancer.JAMA1991https://conductscience.org/library/papers/1984541PubMed
68174045Nuclear immunoreaction of p53 protein in soft tissue sarcomas. A possible prognostic factor.Cancer1994https://conductscience.org/library/papers/8174045PubMed
72228312Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.Int J Cancer1990https://conductscience.org/library/papers/2228312PubMed
81413493Abnormal p53 immunoreactivity and prognosis in node-negative breast carcinomas with long-term follow-up.Virchows Arch A Pathol Anat Histopathol1992https://conductscience.org/library/papers/1413493PubMed
98302577DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture.Oncogene1994https://conductscience.org/library/papers/8302577PubMed
108033152Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.Cancer Res1994https://conductscience.org/library/papers/8033152PubMed
111734086Pattern of p53 gene mutations in breast cancers of women of the midwestern United States.J Natl Cancer Inst1992https://conductscience.org/library/papers/1734086PubMed
121378473An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.J Immunol Methods1992https://conductscience.org/library/papers/1378473PubMed
137506924Problems with p53 immunohistochemical staining: the effect of fixation and variation in the methods of evaluation.Br J Cancer1994https://conductscience.org/library/papers/7506924PubMed
141679056Nuclear p53 immunoreaction associated with poor prognosis of breast cancer.Jpn J Cancer Res1991https://conductscience.org/library/papers/1679056PubMed
153276632P53 expression in breast cancer.Int J Cancer1988https://conductscience.org/library/papers/3276632PubMed
167514027p53 immunohistochemical analysis in breast cancer with four monoclonal antibodies: comparison of staining and PCR-SSCP results.Br J Cancer1994https://conductscience.org/library/papers/7514027PubMed
178252351Correlation between p53 mutations and antibody staining in breast carcinoma.Br J Surg1993https://conductscience.org/library/papers/8252351PubMed
188287224Accumulation of p53 protein as an indicator for p53 gene mutation in breast cancer. Occurrence of false-positives and false-negatives.Diagn Mol Pathol1993https://conductscience.org/library/papers/8287224PubMed
191352359Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients.J Natl Cancer Inst1992https://conductscience.org/library/papers/1352359PubMed
201535557The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.Cell1992https://conductscience.org/library/papers/1535557PubMed

See all 40 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 28 citations.

PMIDTitleJournalYearIn PapersSource
24488925The Mdm network and its regulation of p53 activities: a rheostat of cancer risk.Hum Mutat2014https://conductscience.org/library/papers/24488925PubMed
16154258Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.Cancer Lett2006https://conductscience.org/library/papers/16154258PubMed
15856018Oxidized guanine lesions and hOgg1 activity in lung cancer.Oncogene2005https://conductscience.org/library/papers/15856018PubMed
15064746Genotoxic stress leads to centrosome amplification in breast cancer cell lines that have an inactive G1/S cell cycle checkpoint.Oncogene2004https://conductscience.org/library/papers/15064746PubMed
11250701Transforming growth factor-beta and breast cancer: Cell cycle arrest by transforming growth factor-beta and its disruption in cancer.Breast Cancer Res2000https://conductscience.org/library/papers/11250701PubMed
10189892Overexpression of MDM2 in MCF-7 promotes both growth advantage and p53 accumulation in response to estradiol.Jpn J Cancer Res1999https://conductscience.org/library/papers/10189892PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
MDM24193PubTator's text mininghttps://conductscience.org/library/genes/4193NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9260591

GET https://conductscience.org/api/papers/v1/9260591/references?page=2